Zhejiang Jingxin Pharmaceutical Co., Ltd. (002020) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Zhejiang Jingxin Pharmaceutical Co., Ltd.

Why is Zhejiang Jingxin Pharmaceutical Co., Ltd. ?

Poor long term growth as Net Sales has grown by an annual rate of 3.97% and Operating profit at 7.28% over the last 5 years

Flat results in Mar 26

INTEREST(Q) At CNY 1.17 MM has Grown at inf%
INVENTORY TURNOVER RATIO(HY) Lowest at 2.49 times
NET SALES(Q) Lowest at CNY 923.03 MM

With ROE of 12.44%, it has a very attractive valuation with a 1.46 Price to Book Value

Over the past year, while the stock has generated a return of -5.24%, its profits have risen by 1.5%
At the current price, the company has a high dividend yield of 0

Below par performance in long term as well as near term

Along with generating -5.24% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in the last 3 years, 1 year and 3 months

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to Zhejiang Jingxin Pharmaceutical Co., Ltd. should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Zhejiang Jingxin Pharmaceutical Co., Ltd. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Zhejiang Jingxin Pharmaceutical Co., Ltd.

-5.04%

0.26

43.62%

China Shanghai Composite

20.18%

1.55

13.83%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

3.97%

EBIT Growth (5y)

7.28%

EBIT to Interest (avg)

100.00

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.05

Sales to Capital Employed (avg)

0.65

Tax Ratio

14.81%

Dividend Payout Ratio

38.05%

Pledged Shares

Institutional Holding

ROCE (avg)

15.55%

ROE (avg)

12.57%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.46

EV to EBIT

10.63

EV to EBITDA

8.14

EV to Capital Employed

1.53

EV to Sales

2.01

PEG Ratio

Dividend Yield

ROCE (Latest)

14.40%

ROE (Latest)

12.44%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bearish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Mildly Bearish

Dow Theory

Mildly Bearish

OBV

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

3What is working for the Company

ROCE(HY)

Highest at 12.9%

RAW MATERIAL COST(Y)

Fallen by -11.61% (YoY

-7What is not working for the Company

INTEREST(Q)

At CNY 1.17 MM has Grown at inf%

INVENTORY TURNOVER RATIO(HY)

Lowest at 2.49 times

NET SALES(Q)

Lowest at CNY 923.03 MM

OPERATING PROFIT(Q)

Lowest at CNY 180.81 MM

OPERATING PROFIT MARGIN(Q)

Lowest at 19.59 %

Here's what is working for Zhejiang Jingxin Pharmaceutical Co., Ltd.

Raw Material Cost

Fallen by -11.61% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Zhejiang Jingxin Pharmaceutical Co., Ltd.

Interest

At CNY 1.17 MM has Grown at inf%

period on period (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Net Sales

Lowest at CNY 923.03 MM

in the last five periods

MOJO Watch

Near term sales trend is negative

Net Sales (CNY MM)

Net Sales

At CNY 923.03 MM has Fallen at -9.27%

over average net sales of the previous four periods of CNY 1,017.34 MM

MOJO Watch

Near term sales trend is negative

Net Sales (CNY MM)

Operating Profit

Lowest at CNY 180.81 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (CNY MM)

Operating Profit Margin

Lowest at 19.59 %

in the last five periods

MOJO Watch

Company's profit margin has deteriorated

Operating Profit to Sales

Inventory Turnover Ratio

Lowest at 2.49 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio